Загрузка...
Termination of Bleeding by a Specific, Anti-catalytic Antibody to Plasmin
BACKGROUND: Excessive, plasmin-mediated fibrinolysis augments bleeding and contributes to death in some patients. Current therapies for fibrinolytic bleeding are limited by modest efficacy, low potency and off-target effects. OBJECTIVES: To determine whether an antibody directed against unique loop...
Сохранить в:
| Опубликовано в: : | J Thromb Haemost |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7359864/ https://ncbi.nlm.nih.gov/pubmed/31136076 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.14522 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|